The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Marine Operational Trial

13 Mar 2017 07:00

RNS Number : 2131Z
Quadrise Fuels International PLC
13 March 2017
 

13 March 2017

 

Quadrise Fuels International plc

("Quadrise", "QFI'' or the "Company")

 

Marine Operational Trial

 

Quadrise Fuels International plc (AIM:QFI), the emerging supplier of MSAR® emulsion technology and fuel, enabling a low-cost alternative to heavy fuel oil (one of the world's largest fuels markets, comprising over 450 million tonnes per annum) in the global shipping, refining and power generation markets, announces that the Company has been informed by Maersk Line A/S ("Maersk") of a further update relating to the letter of no objection ("LONO") and MSAR® operational trial on the Maersk nominated vessel.

 

Further to the announcement made on 2 March 2017, regarding the unscheduled dry-docking of the MSAR® trial vessel, Maersk is continuing its efforts to move the test vessel into a suitable dry dock.

 

Maersk has however confirmed that the trial has been successful to date and has also indicated that Wärtsilä will carry out a detailed inspection of the test vessel's engine during the next few months to verify and document the performance of the test vessel while operating on MSAR® fuel, with a view to issuing an "Interim LONO" to confirm the fuel is safe and suitable for the Wärtsilä RT-Flex engine type. 

 

Following an operational redeployment of the vessel upon completion of the dry-docking the vessel will not be able to bunker at Algeciras. As a result, the MSAR® trial will be suspended once the remaining MSAR® fuel on the test vessel has been consumed. Maersk is currently considering alternative test vessels within its fleet for a continuation of the MSAR® trial programme - though it is unlikely that the trial will be resumed before Q4 2017. 

 

Maersk has confirmed that it wants to continue to work with Quadrise to explore the commercial options for Marine MSAR® after the issuance of the Interim LONO.

 

Mike Kirk, Executive Chairman of QFI plc, said:

 

"We are clearly disappointed that Maersk will have to suspend the trial for operational reasons that are unrelated to the MSAR® operational trial. However, we are pleased that Maersk has reconfirmed that the trial to date has been successful and that an interim inspection will be completed in the Spring, as originally scheduled.

 

We look forward to receiving the results of the Interim LONO and working with Maersk to pursue the commercial opportunities for MSAR®. The confirmation of the positive trial programme results to date combined with a positive Interim LONO will enable Quadrise to progress its plans for commercialisation of Marine MSAR®".

 

 

 

Niels H Bruus, Head of Future Solutions of Maersk Line A/S, said:

 

"During the MSAR® trial program Maersk has enjoyed a close and professional collaboration with both our technology partner QFI, and supply partner CEPSA, resulting in a smooth operation during which the fuel has performed well.

 

We look forward to continuing our collaborations and will work with QFI to consider the commercial opportunities of MSAR® while we review options for continuing trials aboard other vessels."

 

This announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For additional information, please contact:

 

Quadrise Fuels International plc +44 (0)20 7031 7321

Mike Kirk

Hemant Thanawala

Jason Miles

 

Smith & Williamson Corporate Finance Limited +44 (0)20 7131 4000

Dr Azhic Basirov

Ben Jeynes

Katy Birkin

 

Peel Hunt LLP +44 (0)20 7418 8900

Richard Crichton

Ross Allister

Chris Burrows

 

FTI Consulting +44 (0)20 3727 1000

Ben Brewerton

Sara Powell

 

 

Notes to Editors

 

QFI has developed MSAR® as a less expensive, cleaner synthetic HFO. Produced using QFI's proprietary technologies and services, MSAR® offers both producers and consumers of the fuel significant economic and environmental advantages. MSAR®, an oil in water emulsion, is made by mixing the residue stream from an oil refinery with water and specialised chemicals in a proprietary production process, instead of diluting the residuals with high value distillate products as in the production of HFO.

 

QFI acts as the technology and service partner to both the producer and the consumer and aims to create value both through licence revenues from the production of fuel and the sale of the chemicals and MSAR® manufacturing systems. The core technology has been developed jointly with AkzoNobel - one of the world's leading surface chemistry companies.

 

The two largest markets for the use of MSAR® as a low cost, efficient and environmentally friendly synthetic HFO are marine bunkering and power generation. Significant work has been carried out to demonstrate the proof of concept in both end-user markets and current work is focused on commercial scale trials the successful conclusion of which will be a significant milestone towards QFI developing sustainable commercial revenues.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDLLFVAVLIFLID
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.